Literature DB >> 1624078

Endotoxin levels in cirrhotic rats with sterile and infected ascites.

S Sugano1.   

Abstract

Endotoxin levels were measured in sterile and bacterially infected ascites in a rat model of phenobarbital and carbon tetrachloride induced cirrhosis was used. An improved chromogenic substrate assay was used to measure endotoxin. All rat ascites specimens were positive for endotoxin. In culture-negative ascites (n = 8), it ranged from 0.05 EU/ml to 0.14 EU/ml (0.08 +/- 0.04 EU/ml, mean +/- SD) (Escherichia coli 0111:B4 endotoxin was used as a reference). In culture-positive ascites (premortem n = 3, postmortem n = 1), it ranged from 0.78 EU/ml to 1.8 EU/ml (1.29 +/- 0.59 EU/ml, mean +/- SD). All rats with premortem culture-positive ascites died within two days. This model is useful to study ascites endotoxin levels. In this study, increasing levels of ascites endotoxin correlated with spontaneous bacterial peritonitis and death.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624078     DOI: 10.1007/bf02777753

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  12 in total

1.  Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: its clinical significance.

Authors:  K Tarao; K So; T Moroi; T Ikeuchi; T Suyama
Journal:  Gastroenterology       Date:  1977-09       Impact factor: 22.682

2.  Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node.

Authors:  E K Steffen; R D Berg; E A Deitch
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

3.  Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients.

Authors:  G Pinzello; R G Simonetti; A Craxì; S Di Piazza; C Spanò; L Pagliaro
Journal:  Hepatology       Date:  1983 Jul-Aug       Impact factor: 17.425

4.  Principles of a quantitative assay for bacterial endotoxins in blood that uses Limulus lysate and a chromogenic substrate.

Authors:  C J Webster
Journal:  J Clin Microbiol       Date:  1980-11       Impact factor: 5.948

5.  Optimization of ascitic fluid culture technique.

Authors:  B A Runyon; H N Canawati; E A Akriviadis
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

6.  Chromogenic substrates for horseshoe crab clotting enzyme. Its application for the assay of bacterial endotoxins.

Authors:  S Iwanaga; T Morita; T Harada; S Nakamura; M Niwa; K Takada; T Kimura; S Sakakibara
Journal:  Haemostasis       Date:  1978

7.  Acetone potentiation of chronic liver injury induced by repetitive administration of carbon tetrachloride.

Authors:  M Charbonneau; B Tuchweber; G L Plaa
Journal:  Hepatology       Date:  1986 Jul-Aug       Impact factor: 17.425

8.  A rodent model of cirrhosis, ascites, and bacterial peritonitis.

Authors:  B A Runyon; S Sugano; G Kanel; M A Mellencamp
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

9.  High yield micronodular cirrhosis in the rat.

Authors:  E Proctor; K Chatamra
Journal:  Gastroenterology       Date:  1982-12       Impact factor: 22.682

10.  Endotoxemia of cirrhosis: an observation not substantiated.

Authors:  J T Fulenwider; C Sibley; S F Stein; B Evatt; B M Nordlinger; G L Ivey
Journal:  Gastroenterology       Date:  1980-05       Impact factor: 22.682

View more
  4 in total

1.  Updates on Hepato-Renal Syndrome.

Authors:  Kyota Fukazawa; H Thomas Lee
Journal:  J Anesth Clin Res       Date:  2013-09-27

Review 2.  Recent advances in our understanding of hepatorenal syndrome.

Authors:  Florence Wong
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-22       Impact factor: 46.802

Review 3.  Management of hepatorenal syndrome in patients with cirrhosis.

Authors:  Vicente Arroyo; Javier Fernández
Journal:  Nat Rev Nephrol       Date:  2011-08-09       Impact factor: 28.314

Review 4.  Acute kidney injury in children with chronic liver disease.

Authors:  Akash Deep; Romit Saxena; Bipin Jose
Journal:  Pediatr Nephrol       Date:  2018-03-01       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.